BACKGROUND: Lumbar plexopathy is considered a rare complication of minimally invasive endovascular or surgical procedures, but it has not been related to the use of extracorporeal membrane oxygenation (ECMO) so far. In cases of high-intensity neuropathic pain, neuromodulation should be considered early in the treatment. CASE REPORT: After receiving supportive ECMO therapy for 7 days, a 42-year-old woman developed lumbar plexopathy and high-intensity neuropathic pain and was referred to the pain unit 6 months later. After unsuccessful use of neuropathic drugs, spinal cord stimulation achieved global improvements of 90%. Sixteen months later, the patient continues to be asymptomatic, leading an active life as a mother of 4 children. CONCLUSIONS: The use of ECMO cannot be said to be the main cause of plexopathy in this case, but a multifactorial approach regarding this issue should be considered. Spinal cord stimulation can provide dramatic relief in localized neuropathic pain. KEY WORDS: Extracorporeal membrane oxygenation (ECMO), lumbosacral plexopathy, spinal cord stimulation
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.